Literature DB >> 19013912

Use of azithromycin ophthalmic solution in the treatment of chronic mixed anterior blepharitis.

Thomas John1, Ami A Shah.   

Abstract

We tested the efficacy of azithromycin ophthalmic solution for the treatment of chronic mixed anterior blepharitis. The findings suggest that patients with chronic mixed anterior blepharitis can be more effectively treated with azithromycin ophthalmic solution than erythromycin ophthalmic ointment. Patients treated with azithromycin ophthalmic solution show an extraordinary clinical response with shorter treatment duration.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19013912

Source DB:  PubMed          Journal:  Ann Ophthalmol (Skokie)        ISSN： 1530-4086


  12 in total

1.  Topical azithromycin and oral doxycycline therapy of meibomian gland dysfunction: a comparative clinical and spectroscopic pilot study.

Authors:  Gary N Foulks; Douglas Borchman; Marta Yappert; Shelley Kakar
Journal:  Cornea       Date:  2013-01       Impact factor: 2.651

Review 2.  Interventions for chronic blepharitis.

Authors:  Kristina Lindsley; Sueko Matsumura; Elham Hatef; Esen K Akpek
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

Review 3.  Dysfunctional tear syndrome: dry eye disease and associated tear film disorders - new strategies for diagnosis and treatment.

Authors:  Mark S Milner; Kenneth A Beckman; Jodi I Luchs; Quentin B Allen; Richard M Awdeh; John Berdahl; Thomas S Boland; Carlos Buznego; Joseph P Gira; Damien F Goldberg; David Goldman; Raj K Goyal; Mitchell A Jackson; James Katz; Terry Kim; Parag A Majmudar; Ranjan P Malhotra; Marguerite B McDonald; Rajesh K Rajpal; Tal Raviv; Sheri Rowen; Neda Shamie; Jonathan D Solomon; Karl Stonecipher; Shachar Tauber; William Trattler; Keith A Walter; George O Waring; Robert J Weinstock; William F Wiley; Elizabeth Yeu
Journal:  Curr Opin Ophthalmol       Date:  2017-01       Impact factor: 3.761

4.  Topical azithromycin therapy for meibomian gland dysfunction: clinical response and lipid alterations.

Authors:  Gary N Foulks; Douglas Borchman; Marta Yappert; Sung-Hye Kim; John W McKay
Journal:  Cornea       Date:  2010-07       Impact factor: 2.651

Review 5.  Understanding Neuropathic Corneal Pain--Gaps and Current Therapeutic Approaches.

Authors:  Sunali Goyal; Pedram Hamrah
Journal:  Semin Ophthalmol       Date:  2016       Impact factor: 1.975

6.  Comparison of therapeutic effects of topical azithromycin solution and systemic doxycycline on posterior blepharitis.

Authors:  Mehdi Zandian; Neda Rahimian; Sanaz Soheilifar
Journal:  Int J Ophthalmol       Date:  2016-07-18       Impact factor: 1.779

7.  Review of Azithromycin Ophthalmic 1% Solution (AzaSite(®)) for the Treatment of Ocular Infections.

Authors:  Dominick L Opitz; Jennifer S Harthan
Journal:  Ophthalmol Eye Dis       Date:  2012-02-23

8.  A Phase III clinical study to evaluate the efficacy of combined azithromycin and dexamethasone in the treatment of blepharoconjunctivitis.

Authors:  Kamran Hosseini; Judith Hutcheson; Richard L Lindstrom
Journal:  Clin Ophthalmol       Date:  2013-11-11

9.  A European perspective on topical ophthalmic antibiotics: current and evolving options.

Authors:  D Bremond-Gignac; F Chiambaretta; S Milazzo
Journal:  Ophthalmol Eye Dis       Date:  2011-10-24

10.  A randomized, double-masked, parallel-group, comparative study to evaluate the clinical efficacy and safety of 1% azithromycin-0.1% dexamethasone combination compared to 1% azithromycin alone, 0.1% dexamethasone alone, and vehicle in the treatment of subjects with blepharitis.

Authors:  Kamran Hosseini; Richard L Lindstrom; Gary Foulks; Kelly K Nichols
Journal:  Clin Ophthalmol       Date:  2016-08-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.